Literature DB >> 18521294

Adjuvant chemotherapy of soft tissue sarcoma-current status.

I Judson1.   

Abstract

Entities:  

Year:  2000        PMID： 18521294      PMCID： PMC2395442          DOI： 10.1080/13577140020025850

Source DB:  PubMed          Journal:  Sarcoma        ISSN： 1357-714X


× No keyword cloud information.
  6 in total

1.  Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity.

Authors:  J C Yang; A E Chang; A R Baker; W F Sindelar; D N Danforth; S L Topalian; T DeLaney; E Glatstein; S M Steinberg; M J Merino; S A Rosenberg
Journal:  J Clin Oncol       Date:  1998-01       Impact factor: 44.544

2.  The reason for confining the use of adjuvant chemotherapy in soft tissue sarcoma to the investigational setting.

Authors:  J Verweij; C Seynaeve
Journal:  Semin Radiat Oncol       Date:  1999-10       Impact factor: 5.934

3.  Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma--reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.

Authors:  V Bramwell; J Rouesse; W Steward; A Santoro; H Schraffordt-Koops; J Buesa; W Ruka; J Priario; T Wagener; M Burgers
Journal:  J Clin Oncol       Date:  1994-06       Impact factor: 44.544

4.  Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.

Authors:  A Santoro; T Tursz; H Mouridsen; J Verweij; W Steward; R Somers; J Buesa; P Casali; D Spooner; E Rankin
Journal:  J Clin Oncol       Date:  1995-07       Impact factor: 44.544

5.  Adjuvant chemotherapy for soft-tissue sarcoma: review and meta-analysis of the published results of randomised clinical trials.

Authors:  J F Tierney; V Mosseri; L A Stewart; R L Souhami; M K Parmar
Journal:  Br J Cancer       Date:  1995-08       Impact factor: 7.640

6.  Intensified Adjuvant IFADIC Chemotherapy for Adult Soft Tissue Sarcoma: A Prospective Randomized Feasibility Trial.

Authors:  T Brodowicz; E Schwameis; J Widder; G Amann; C Wiltschke; M Dominkus; R Windhager; P Ritschl; R Pötter; R Kotz; C C Zielinski
Journal:  Sarcoma       Date:  2000
  6 in total
  1 in total

Review 1.  Adjuvant chemotherapy in 2011 for patients with soft-tissue sarcoma.

Authors:  Igor Matushansky; Robert N Taub
Journal:  Nat Rev Clin Oncol       Date:  2011-03-22       Impact factor: 66.675
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.